Science has revolutionized our understanding of cellular diversity and revealed a vast array of unique cell types, thus forging a new age of cellular medicines. To realize these breakthroughs, Landmark Bio’s cell therapy services leverage next-generation capabilities and know-how to manipulate, scale and manufacture cell therapies for oncology, regenerative medicine, autoimmune disease and rare disease.
Discover how our cutting-edge capabilities can help you bring innovative cell therapies to life.
Development & cGMP Manufacturing Services for CAR-T and CAR-NK Therapies
The introduction of chimeric antigen receptors (CARs) into diverse cells of the immune system remains one of the most promising areas of disease research and treatment.
Landmark Bio’s modular and reconfigurable cGMP manufacturing services are designed to support CAR-T and CAR-NK clinical and commercial production, providing vein-to-vein support for autologous and allogenic therapies.
Development and cGMP Manufacturing Services for Novel Cell Therapies
Landmark Bio’s modular and reconfigurable cGMP manufacturing services are designed to support cell therapy clinical and commercial production, providing vein-to-vein support for autologous and allogenic therapies. Landmark Bio’s cell therapy team possesses robust capabilities and know-how across a broad spectrum of cell types, including iPSCs, MSCs, HSCs, PSCs, etc.